Evidence map›Paper›PMID 34016295›Full record

ArticleJournal of substance abuse treatment2021

A real-world ten-week follow-up of the COVID outbreak in an outpatient drug clinic in Salamanca (Spain).

Lourdes Aguilar, Begoña Vicente-Hernández, Diego Remón-Gallo, Llanyra García-Ullán, Isabel Valriberas-Herrero, Ana Maciá-Casas, Ana Pérez-Madruga, Maria Ángeles Garzón, Ana Álvarez-Navares, Carlos Roncero

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Lourdes AguilarPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Begoña Vicente-HernándezPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Diego Remón-GalloPsychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Llanyra García-UllánPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Isabel Valriberas-HerreroPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Ana Maciá-CasasPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Ana Pérez-MadrugaPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Maria Ángeles GarzónPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Ana Álvarez-NavaresPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Carlos RonceroPsychiatry Service, University of Salamanca Health Care Complex, Paseo de San Vicente 58-182, 37007 Salamanca, Spain; Psychiatric Unit, School of Medicine, University of Salamanca (Spain), Alfonso X El Sabio Street, 37007 Salamanca, Spain; Institute of Biomedicine, University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain. Electronic address: croncero@saludcastillayleon.es.
Universidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare over ten weeks the number of relapses, hospital admissions, calls made, admissions to therapeutic communities, face-to-face visits, treatment adjustment, number of injectables administered, and number of emergencies attended due to emotional and behavioral alterations and/or substance use disorder, and to describe and quantify social emergencies in an outpatient drug clinic (ODC) in Salamanca (Spain) from March 16, 2020, to May 22, 2020.

methodsThis is an ecological study of the COVID pandemic over ten weeks. The study examines the set of alcohol or other drug-dependent or dual disorder patients in the population of Salamanca, Spain. The measurements were: professionals; calls made; percentage of successful calls; face-to-face visits; first visits made; reviews made; techniques; injectable treatments; other treatments; evolution; relapses. The ODC includes about 375 new patients each year and another 650 other patients annually.

resultsThe study found the number of relapses to be greater in the last five weeks of the 10-week study period. Patients' psychopathological instability also increased, and face-to-face visits were necessary. The most frequent psychopathology that required face-to-face intervention was depressive disorder. The number of interventions with patients increased. In parallel, social workers' efforts were greater after the seventh week. There was a decrease in response to calls. Throughout this time, the ODC attended to patients who needed to be treated for the first time.

conclusionsConfinement due to the coronavirus pandemic generated maladaptive emotional responses and other behaviors, such as excessive alcohol consumption. The number of face-to-face consultations, admissions, and referrals to therapeutic communities increased. Patients under stress and in social isolation resorted more often to substance use. The ODC had to adopt a flexible approach to evaluate patients with more serious problems, by using face-to-face assessments.

Indexed as

Disease OutbreaksSubstance Abuse Treatment CentersCOVID-19Follow-Up StudiesHumansMental HealthOutpatientsPsychopathologySpainSubstance-Related DisordersAlcoholCOVIDDual disordersFollow-upPhone consultationRelapse

Identifiers

PMID34016295
PMCPMC8065063
OpenAlexW3125055216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.